Your browser doesn't support javascript.
loading
Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.
Hayes, Tikvah K; Aquilanti, Elisa; Persky, Nicole S; Yang, Xiaoping; Kim, Erica E; Brenan, Lisa; Goodale, Amy B; Alan, Douglas; Sharpe, Ted; Shue, Robert E; Westlake, Lindsay; Golomb, Lior; Silverman, Brianna R; Morris, Myshal D; Fisher, Ty Running; Beyene, Eden; Li, Yvonne Y; Cherniack, Andrew D; Piccioni, Federica; Hicks, J Kevin; Chi, Andrew S; Cahill, Daniel P; Dietrich, Jorg; Batchelor, Tracy T; Root, David E; Johannessen, Cory M; Meyerson, Matthew.
Afiliação
  • Hayes TK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
  • Aquilanti E; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Persky NS; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.
  • Yang X; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
  • Kim EE; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Brenan L; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Goodale AB; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Alan D; Aera Therapeutics, Cambridge, MA, USA.
  • Sharpe T; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Shue RE; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
  • Westlake L; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Golomb L; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Silverman BR; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Morris MD; Data Science Platform, The Broad Institute of M.I.T. and Harvard Cambridge, Cambridge, MA, USA.
  • Fisher TR; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
  • Beyene E; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Li YY; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
  • Piccioni F; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Hicks JK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
  • Chi AS; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.
  • Cahill DP; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.
  • Dietrich J; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.
  • Batchelor TT; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
  • Root DE; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
  • Johannessen CM; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
  • Meyerson M; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.
Nat Commun ; 15(1): 3273, 2024 Apr 16.
Article em En | MEDLINE | ID: mdl-38627431

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido